Duale Reihe Anatomie G Aumüller, G Aust, A Conrad, J Engele, J Kirsch, G Maio, A Mayerhofer, ... Thieme, 2020 | 547 | 2020 |
Intranasal delivery of cells to the brain L Danielyan, R Schäfer, A von Ameln-Mayerhofer, M Buadze, J Geisler, ... European journal of cell biology 88 (6), 315-324, 2009 | 349 | 2009 |
Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease L Danielyan, R Schäfer, A von Ameln-Mayerhofer, F Bernhard, ... Rejuvenation research 14 (1), 3-16, 2011 | 277 | 2011 |
The neurobehavioral changes induced by bilateral rotenone lesion in medial forebrain bundle of rats are reversed by L-DOPA M Alam, A Mayerhofer, WJ Schmidt Behavioural brain research 151 (1-2), 117-124, 2004 | 89 | 2004 |
Changes in serotonin, dopamine and noradrenaline levels in striatum and nucleus accumbens after repeated administration of the abused drug MDMA in rats A Mayerhofer, KA Kovar, WJ Schmidt Neuroscience letters 308 (2), 99-102, 2001 | 71 | 2001 |
Rewarding effects of the optical isomers of 3, 4-methylenedioxy-methylamphetamine (‘Ecstasy’) and 3, 4-methylenedioxy-ethylamphetamine (‘Eve’) measured by conditioned place … A Meyer, A Mayerhofer, KA Kovar, WJ Schmidt Neuroscience letters 330 (3), 280-284, 2002 | 60 | 2002 |
Ecstasy counteracts catalepsy in rats, an anti-parkinsonian effect? WJ Schmidt, A Mayerhofer, A Meyer, KA Kovar Neuroscience letters 330 (3), 251-254, 2002 | 52 | 2002 |
Effect of 6-hydroxydopamine (6-OHDA) on proliferation of glial cells in the rat cortex and striatum: evidence for de-differentiation of resident astrocytes B Wachter, S Schürger, J Rolinger, A von Ameln-Mayerhofer, D Berg, ... Cell and tissue research 342, 147-160, 2010 | 50 | 2010 |
A neurocomputational account of catalepsy sensitization induced by D2 receptor blockade in rats: context dependency, extinction, and renewal TV Wiecki, K Riedinger, A von Ameln-Mayerhofer, WJ Schmidt, MJ Frank Psychopharmacology 204, 265-277, 2009 | 48 | 2009 |
Continuous versus pulsatile administration of rotigotine in 6-OHDA-lesioned rats: contralateral rotations and abnormal involuntary movements WJ Schmidt, H Lebsanft, M Heindl, M Gerlach, E Gruenblatt, P Riederer, ... Journal of Neural Transmission 115, 1385-1392, 2008 | 42 | 2008 |
Enantioselective metabolism of the designer drugs 3, 4-methylenedioxymethamphetamine (‘ecstasy’) and 3, 4-methylenedioxyethylamphetamine (‘eve’) isomers in rat brain and blood A Meyer, A Mayerhofer, KA Kovar, WJ Schmidt Neuroscience letters 330 (2), 193-197, 2002 | 29 | 2002 |
Anticataleptic activity of cathinone and MDMA (Ecstasy) upon acute and subchronic administration in rat MY Banjaw, A Mayerhofer, WJ Schmidt Synapse 49 (4), 232-238, 2003 | 27 | 2003 |
Short-and long-term unilateral 6-hydroxydopamine lesions in rats show different changes in characteristics of spontaneous firing of substantia nigra pars reticulata neurons S Seeger-Armbruster, A von Ameln-Mayerhofer Experimental brain research 224, 15-24, 2013 | 26 | 2013 |
Is the Ecstasy-induced ipsilateral rotation in 6-hydroxydopamine unilaterally lesioned rats dopamine independent? HB Lebsanft, A Mayerhofer, KA Kovar, WJ Schmidt Journal of neural transmission 110, 707-718, 2003 | 26 | 2003 |
Anatomie. 4., aktualisierte Auflage G Aumüller, G Aust, J Engele, J Kirsch, G Maio, A Mayerhofer, S Mense, ... Stuttgart: Thieme, 2017 | 21 | 2017 |
Chronic co-administration of the cannabinoid receptor agonist WIN55, 212-2 during puberty or adulthood reverses 3, 4 methylenedioxymetamphetamine (MDMA)-induced deficits in … S Schulz, T Becker, U Nagel, A von Ameln-Mayerhofer, M Koch Pharmacology Biochemistry and Behavior 106, 91-100, 2013 | 18 | 2013 |
In vivo quantification of dopamine transporters in mice with unilateral 6-OHDA lesions using [11C] methylphenidate and PET K Fischer, V Sossi, A von Ameln-Mayerhofer, G Reischl, BJ Pichler Neuroimage 59 (3), 2413-2422, 2012 | 18 | 2012 |
Imaging DA release in a rat model of L-DOPA-induced dyskinesias: A longitudinal< i> in vivo</i> PET investigation of the antidyskinetic effect of MDMA NY Lettfuss, K Fischer, V Sossi, BJ Pichler, A von Ameln-Mayerhofer Neuroimage 63 (1), 423-33, 2012 | 14 | 2012 |
The role of NMDA and AMPA/Kainate receptors in the consolidation of catalepsy sensitization K Riedinger, A Kulak, WJ Schmidt, A von Ameln-Mayerhofer Behavioural brain research 218 (1), 194-199, 2011 | 12 | 2011 |
Modulating endothelial adhesion and migration impacts stem cell therapies efficacy R Schäfer, M Schwab, G Siegel, A von Ameln-Mayerhofer, M Buadze, ... EBioMedicine 60, 2020 | 11 | 2020 |